Metsera, Inc. Common Stock (MTSR NASDAQ) stock market data APIs
$83.3845
-2.54(-3%)
as of November 7, 2025
Try our APIs with
free plan!
Metsera, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Metsera, Inc., a clinical-stage biotechnology company, develops injectable and oral nutrient stimulated hormone analog peptides to treat obesity, overweight, and related diseases. It develops MET-097i and MET-233i for the treatment of obesity and overweight; MET-233i/MET-097i; and MET-002, MET-224o, MET-067i, and MET-034i to treat disorders, such as diabetes and obesity, as well as MET-815i to reduce weight or prevents weight gain. The company was incorporated in 2022 and is based in New York, New York.
Prev. Close
83.3845
Open
80.8402
High
83.4407
Low
80.9027
52 wk Range
12.3-83.86
Market Cap
4 124 M
Shares Outstanding
105 M
EPS
-0.6551
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Metsera, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Metsera, Inc. Common Stock data using free add-ons & libraries
Get Metsera, Inc. Common Stock Fundamental Data
Metsera, Inc. Common Stock Fundamental data includes:
- Net Revenue:
- EBITDA: -178 196 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-29
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Metsera, Inc. Common Stock News
New
Key deals this week: ITV-Sky, Metsera, Kyndryl, SM Energy, KNOT Offshore, Sonida Senior and more
Here's a list of key deals reported across sectors this week: British broadcaster ITV (OTCPK:ITVPF [https://seekingalpha.com/symbol/ITVPF#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbu...
Trending stocks this week: Wall Street ends lower amid AI jitters, weak consumer sentiment
[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images Wall Street finished a choppy week in the red as risk-off sentiment took hold, driven by mounting concerns over stretched AI valua...
Pfizer clinches deal for obesity drug developer Metsea after a bidding war with Novo Nordisk
NEW YORK (AP) — U.S. pharmaceutical giant Pfizer signed a deal to purchase development-stage obesity drugmaker Metsera Inc., winning a bidding war against Novo Nordisk, the Danish drugmaker behind w...
Pfizer wins $10 billion Metsera bidding war as Novo Nordisk exits
STORY: U.S. drugmaker Pfizer has clinched a $10 billion deal for obesity drug developer Metsera.It ended the biotech bidding war with Danish rival Novo Nordisk, which announced Saturday (November 8) i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
